A continuous biomanufacturing platform can process higher/lower quantities of a drug as needed and allow manufacturers to respond to changing markets.
Jeffery Odum
Advertisement
Jeffery Odum is a consultant with NCBiosource.
Articles by Jeffery Odum
Advertisement
Latest Updated Articles
Advertisement
Advertisement
